Congress is in session
In-person conferences are back, but there is an urgency to reach a more diverse, inclusive audience through dynamic programmes and immersive technology. In Danny Buckland’s article, he looks at how companies are boosting their impact and engagement.
As Danny says: “Delegates have been flocking back to face-to-face congresses after the pandemic’s drought but hybrid events are becoming the norm by offering healthcare professionals, academia and industry staff the ability to attend or connect virtually and tailor their consumption.”
He goes on to say that while “there is little sign that in-person events are fading in popularity...the word ‘hybrid’ remains a focus as organisers seek to offer the best of both mediums.” Read more on page 28.
In our interview with Scott Curley, general manager of Amarin, UK and Ireland, he talks about the risks of cardiovascular disease (CVD) and the importance of getting the right treatment at the right time. In the article, he looks at the impact of the pandemic on care for patients with CVD, how the government and the NHS are working together to improve patient care, and the best steps patients can take to protect against an increased risk of CVD. Read more on page 16.
Looking ahead, our April issue will focus on the vital role of behavioural change in healthcare.
There is overwhelming evidence that small changes in health-related behaviour can have a significant impact on people’s health and life expectancy. In our next issue we will look at the challenges and benefits of implementing and maintaining behaviour change for both individuals and healthcare providers.
If you would like to make your voice heard on these topics, please get in touch at sales@pmlive.com
I hope you enjoy this issue!
View Pharmaceutical Market Europe - March 2023 online
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...